F. Krammer
Infectious Diseases · 2013–2021
A researcher in the Science corpus: 21 papers; trusts 7 researchers and is trusted by 11 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 249 citations into it; #226 of 589 by trust here, #62 by citations
- Epidemiology — 121 citations into it; #529 of 2,148 by trust here, #664 by citations
- Immunology — 77 citations into it; #596 of 2,160 by trust here, #1,035 by citations
- Animal Science and Zoology — 56 citations into it
- Agronomy and Crop Science — 13 citations into it
Whom F. Krammer trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts F. Krammer overall
- Alexander A. Cohen
- Zhi Yang
- Wendy K. Jo
- M. Kanekiyo
- L. van der Hoek
- Priyanthi N P Gnanapragasam
- Rachel T. Eguia
- Alessandro Sette
Papers from F. Krammer's perspective
Ordered by how strongly the researchers F. Krammer trusts endorse each paper. Same corpus, a different order for every researcher.
- Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. (Annual Review of Biochemistry)
- Structure, Function, and Evolution of Coronavirus Spike Proteins (Annual Review of Virology)
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
- Antibody recognition of a highly conserved influenza virus epitope: implications for universal prevention and therapy
- Structural and Functional Bases for Broad-Spectrum Neutralization of Avian and Human Influenza A Viruses (Nature Structural &Molecular Biology)
- Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. (New England Journal of Medicine)
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- Structural basis of receptor recognition by SARS-CoV-2
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset (Journal of Infectious Diseases)
Their papers
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals (2020) — 3,322 citations
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses (2021) — 724 citations
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine (2021) — 704 citations
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection (2021) — 2,530 citations
- SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup (2020) — 688 citations
- SARS-CoV-2 vaccines in development (2020) — 1,865 citations
- A serological assay to detect SARS-CoV-2 seroconversion in humans (2020) — 686 citations
- A serological assay to detect SARS-CoV-2 seroconversion in humans (2020) — 1,228 citations
- Robust neutralizing antibodies to SARS-CoV-2 infection persist for months (2020) — 1,071 citations
- A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection (2020) — 200 citations
- Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development (2020) — 998 citations
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 (2020) — 2,027 citations
- SARS-CoV-2 Vaccines: Status Report (2020) — 1,041 citations
- The human antibody response to influenza A virus infection and vaccination (2019) — 689 citations
- Novel correlates of protection against pandemic H1N1 influenza A virus infection (2019) — 168 citations
- A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains (2019) — 59 citations
- Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach (2019) — 68 citations
- Influenza (2018) — 1,146 citations
- Immune history profoundly affects broadly protective B cell responses to influenza (2015) — 398 citations
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans (2014) — 248 citations